Literature DB >> 26204462

Glucocorticoid-Induced Preterm Birth and Neonatal Hyperglycemia Alter Ovine β-Cell Development.

Amita Bansal1, Frank H Bloomfield1, Kristin L Connor1, Mike Dragunow1, Eric B Thorstensen1, Mark H Oliver1, Deborah M Sloboda1, Jane E Harding1, Jane M Alsweiler1.   

Abstract

Adults born preterm are at increased risk of impaired glucose tolerance and diabetes. Late gestation fetuses exposed to high blood glucose concentration also are at increased risk of impaired glucose tolerance as adults. Preterm babies commonly become hyperglycemic and are thus exposed to high blood glucose concentration at an equivalent stage of pancreatic maturation. It is not known whether preterm birth itself, or complications of prematurity, such as hyperglycemia, alter later pancreatic function. To distinguish these, we made singleton preterm lambs hyperglycemic (HYPER) for 12 days after birth with a dextrose infusion and compared them with vehicle-treated preterm and term controls and with HYPER lambs made normoglycemic with an insulin infusion. Preterm birth reduced β-cell mass, apparent by 4 weeks after term and persisting to adulthood (12 mo), and was associated with reduced insulin secretion at 4 months (juvenile) and reduced insulin mRNA expression in adulthood. Hyperglycemia in preterm lambs further down-regulated key pancreatic gene expression in adulthood. These findings indicate that reduced β-cell mass after preterm birth may be an important factor in increased risk of diabetes after preterm birth and may be exacerbated by postnatal hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26204462     DOI: 10.1210/en.2015-1095

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Insights Into the Progression of β-Cell Dysfunction Caused by Preterm Birth.

Authors:  Sean W Limesand
Journal:  Endocrinology       Date:  2015-10       Impact factor: 4.736

2.  Postnatal effects of intrauterine treatment of the growth-restricted ovine fetus with intra-amniotic insulin-like growth factor-1.

Authors:  A M Spiroski; M H Oliver; A L Jaquiery; T C R Prickett; E A Espiner; J E Harding; F H Bloomfield
Journal:  J Physiol       Date:  2017-12-27       Impact factor: 5.182

3.  Sex- and Dose-Specific Effects of Maternal Bisphenol A Exposure on Pancreatic Islets of First- and Second-Generation Adult Mice Offspring.

Authors:  Amita Bansal; Cetewayo Rashid; Frances Xin; Changhong Li; Erzsebet Polyak; Anna Duemler; Tom van der Meer; Martha Stefaniak; Sana Wajid; Nicolai Doliba; Marisa S Bartolomei; Rebecca A Simmons
Journal:  Environ Health Perspect       Date:  2017-09-27       Impact factor: 9.031

4.  The microbial biogeography of the gastrointestinal tract of preterm and term lambs.

Authors:  Clara Yieh Lin Chong; Tommi Vatanen; Mark Oliver; Frank H Bloomfield; Justin M O'Sullivan
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

5.  Preterm birth and risk of type 1 and type 2 diabetes: a national cohort study.

Authors:  Casey Crump; Jan Sundquist; Kristina Sundquist
Journal:  Diabetologia       Date:  2019-12-05       Impact factor: 10.122

6.  Preterm Birth and Birth Weight and the Risk of Type 1 Diabetes in Chinese Children.

Authors:  Ke Huang; Shuting Si; Ruimin Chen; Chunlin Wang; Shaoke Chen; Yan Liang; Hui Yao; Rongxiu Zheng; Fang Liu; Binyan Cao; Zhe Su; Maimaiti Mireguli; Feihong Luo; Pin Li; Hongwei Du; Min Zhu; Yu Yang; Lanwei Cui; Yunxian Yu; Junfen Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

7.  Intermittent bolus feeding does not enhance protein synthesis, myonuclear accretion, or lean growth more than continuous feeding in a premature piglet model.

Authors:  Marko Rudar; Jane K Naberhuis; Agus Suryawan; Hanh V Nguyen; Barbara Stoll; Candace C Style; Mariatu A Verla; Oluyinka O Olutoye; Douglas G Burrin; Marta L Fiorotto; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-11-01       Impact factor: 4.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.